Methyl Indole-4-Carboxylate CAS 39830-66-5 Tsarkake>98.0% (HPLC) Hoton Babban Ingancin Factory

Methyl Indole-4-Carboxylate CAS 39830-66-5 Tsarkake>98.0% (HPLC) Babban Ingancin Masana'anta

Takaitaccen Bayani:

Sunan Kemikal: Methyl Indole-4-Carboxylate

Saukewa: 39830-66-5

Tsafta:> 98.0% (HPLC)

Kodadde Rawaya zuwa Kodadde Jajayen Crystal Crystal ko Foda

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai ba da kayayyaki na Methyl Indole-4-Carboxylate (CAS: 39830-66-5) tare da babban inganci, samar da kasuwanci.Maraba don yin oda.

Abubuwan Sinadarai:

Sunan Sinadari	Methyl Indole-4-Carboxylate
Makamantu	Methyl 4-Indolecarboxylate;Indole-4-Carboxylic Acid Methyl Ester
Lambar CAS	39830-66-5
Lambar CAT	Saukewa: RF-PI1555
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C10H9NO2
Nauyin Kwayoyin Halitta	175.19
Solubility	Mai narkewa a cikin methanol
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Kodadde Rawaya zuwa Kodadde Jajayen Crystal Crystal ko Foda
1 H NMR Spectrum	Daidaita Da Tsarin
Tsarkake / Hanyar Bincike	98.0% (HPLC)
Matsayin narkewa	68.0 ~ 71.0 ℃ (lit.)
Asara akan bushewa	<1.00%
Ragowa akan Ignition	<0.20%
Jimlar ƙazanta	<2.00%
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Matsakaicin Magunguna

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

FAQ:

Aikace-aikace:

Methyl Indole-4-Carboxylate (CAS: 39830-66-5),Mai amsawa don shirye-shiryen masu hanawa na tryptophan dioxygenase pyridyl-ehenyl-indoles a matsayin m anticancer immunomodulators;Mai amsawa don shirye-shiryen jami'ai na cytotoxic akan ƙwayoyin kansa masu jurewa da yawa;Mai amsawa don shirye-shiryen mai hanawa don β-tryptase;Mai amsawa don shirye-shiryen histamine H3 antagonists;Mai amsawa don shirye-shiryen JNK3 MAP kinase inhibitors;Reactant don shirye-shiryen nucleosides.